Atlas Trials

Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation

Clinical trial NCT02275936 · COMPLETED

Trial details

NCT number
NCT02275936
Sponsor
Nivalis Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2015-02-01
Primary completion
2015-07-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.